No. (%) | |
---|---|
Sex | |
Male | 26 (29.2%) |
Female | 63 (70.8%) |
Age (years) | |
Mean ± SD. | 50.1 ± 9.9 |
Median (min.–max.) | 50 (27–65) |
BMI (kg/m2) | |
Mean ± SD. | 26.9 ± 2 |
Median (min.–max.) | 27.1(22.9–29.9) |
HCV PCR | |
Mean ± SD. | 918883.5 ± 1228408 |
Median (min.–max.) | 336000 (5592–5330000) |
Liver echogenicity | |
Normal | 61 (68.5%) |
Cirrhotic | 28 (31.5%) |
Spleen (US) | |
Normal | 79 (88.8%) |
Enlarged | 10 (11.2%) |
FIB4 score | |
Mean ± SD. | 1.7 ± 0.9 |
Median (min.–max.) | 1.5 (0.6–5.2) |
APRI score | |
Mean ± SD. | 0.6 ± 0.4 |
Median (min.–max.) | 0.5 (0.1–1.9) |
Type of drugs | |
SOF + DAC | 63(70.8%) |
SOF + DAC + RIB | 26(29.2%) |